Does ADALIMUMAB-AATY Cause Hospitalisation? 50 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Hospitalisation have been filed in association with ADALIMUMAB-AATY (Yuflyma). This represents 3.0% of all adverse event reports for ADALIMUMAB-AATY.
50
Reports of Hospitalisation with ADALIMUMAB-AATY
3.0%
of all ADALIMUMAB-AATY reports
2
Deaths
50
Hospitalizations
How Dangerous Is Hospitalisation From ADALIMUMAB-AATY?
Of the 50 reports, 2 (4.0%) resulted in death, 50 (100.0%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB-AATY. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB-AATY Cause?
Intentional dose omission (338)
Drug ineffective (151)
Intentional product use issue (151)
Death (132)
Arthralgia (96)
Rheumatoid arthritis (94)
Fatigue (92)
Therapy interrupted (88)
Crohn's disease (87)
Headache (86)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which ADALIMUMAB-AATY Alternatives Have Lower Hospitalisation Risk?
ADALIMUMAB-AATY vs ADALIMUMAB-ADAZ
ADALIMUMAB-AATY vs ADALIMUMAB-ADBM
ADALIMUMAB-AATY vs ADALIMUMAB-AFZB
ADALIMUMAB-AATY vs ADALIMUMAB-ATTO
ADALIMUMAB-AATY vs ADALIMUMAB-BWWD